from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1147/-

LFCtreatmentdescriptionclass of inhibitor

-0.067

Amikacinug/mL Amikacintranslation

-1.065

Cap5-10ug/mL Capreomycintranslation

-1.186

Rox10-50 ug/mL Roxithromycintranslation

0.014

SM2-5 ug/mL Streptomycintranslation

0.559

Tet5-10 ug/mL Tetracyclinetranslation

1.205

Rif0.2-5ug/mL Rifampicintranscription

0.251

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.216

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.978

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.489

CPZ10-50 ug/mL Chlorpromazinerespiration

0.037

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.563

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.037

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.288

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.152

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.924

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.114

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.491

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.621

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.330

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.360

KCN5-20 ug/mL Potassium cyaniderespiration

-0.788

NaN30.2-2 mM Sodium aziderespiration

-1.030

Nigericin50 uM Nigericinrespiration

0.982

TRC10-150 ug/mL Triclosanrespiration

0.662

TRZ10-25 ug/mL Thioridazinerespiration

-0.928

Valinomycin0.5-10 uM Valinomycinrespiration

-1.788

ZnSO42 mM ZnSO4respiration

0.456

menadione6-10 ug/mL Menadionerespiration

0.037

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.600

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.045

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.974

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.530

NRP_1Non-replicating persistence stage 1dosRassociated

0.017

Amp0.2mg/mL AmpicillincellWall

0.122

Cephalexin20-100 ug/mL CephalexincellWall

-0.667

Cerulenin0.32-5 ug/mL CerulenincellWall

1.874

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.541

EMB10-20 ug/mL EthambutolcellWall

-0.750

Eta12-40 ug/mL EthionamidecellWall

-1.204

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.010

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.717

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.273

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.406

BZA0.12 mg/mL BenzamidearomaticAmides

0.270

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.197

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.316

H2O24 mM hydrogen peroxideDNAdamaging

-0.216

Levo10 ug/mL LevofloxacinDNAdamaging

0.119

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.139

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.500

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.525

UVUV-irradiationDNAdamaging

0.710

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.378

Antimycin12.5-50 ug/mL Antimycin A?

0.145

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.344

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.296

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.415

PA8240.2-2 ug/mL PA-824?

0.147

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.214

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.016

Verapamil50 uM Verapamil?

0.343

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.183

methoxatin10-20 ug/mL Methoxatin?